CORCEPT THERAPEUTICS INC
Develops and commercializes cortisol-modulating drugs for severe disorders like Cushing's syndrome.
CORT | US
Overview
Corporate Details
- ISIN(s):
- US2183521028
- LEI:
- Country:
- United States of America
- Address:
- 101 REDWOOD SHORES PARKWAY, 94065 REDWOOD CITY
- Website:
- https://www.corcept.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Corcept Therapeutics is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of medications that modulate the effects of cortisol. The company's scientific approach centers on regulating cortisol activity at the glucocorticoid receptor (GR) to develop novel treatments for severe disorders. Its lead product, Korlym®, is approved for treating hyperglycemia associated with endogenous Cushing's syndrome. Corcept is advancing a broad clinical pipeline of selective cortisol modulators for a range of diseases across key therapeutic areas, including endocrinology, oncology, metabolism, and neurology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CORCEPT THERAPEUTICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CORCEPT THERAPEUTICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CORCEPT THERAPEUTICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
